Atorvastatin Calcium
- Product NDC
- 71335-2591
- 11-digit product format
- 713352591
- Labeler code
- 71335
- Product ID
- 71335-2591_11e721da-80b6-4730-ad52-ad11ec164696
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atorvastatin calcium, film coated
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209912
- Marketing category
- ANDA
- Marketing start
- 2023-10-20
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209912-001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | |
| A209912-002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | |
| A209912-003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | |
| A209912-004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209912-001 | AB |
| A209912-002 | AB |
| A209912-003 | AB |
| A209912-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2018-06-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2018-06-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2018-06-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2018-06-18 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A209912-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209912-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209912-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209912-004 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A209912-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209912-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209912-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209912-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209912-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209912-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209912-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209912-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209912-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209912-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209912-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209912-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209912-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209912-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209912-004 | AB | 1 | 2680178bc6a6… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atorvastatin Calcium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATORVASTATIN CALCIUM TRIHYDRATE | 40 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 48A5M73Z4Q | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 617311 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9c58c4cd-fe1c-4db7-832c-874766e4da21 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fa898d56-9495-d6f0-309b-68a5d8e3914a | Product name | 4 | 20260305 |
| d25cba4b-d79e-4890-8837-1382f7d09489 | Product name | 1 | 20231002 |
| 91774e91-b249-45e3-8ff8-4b5db2927a69 | Product name | 1 | 20230718 |
| 03fb3cda-d60a-4873-94e9-6fa77cfb1a1c | Product name | 1 | 20220302 |
| 34152997-af0b-acf4-dcaf-37211afe8ca4 | Product name | 9 | 20210312 |
| 46fdf265-6d5a-1bfb-93db-d82a4ea8aa81 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-2591-1 | Atorvastatin Calcium | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 71335-2591-2 | Atorvastatin Calcium | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 71335-2591-3 | Atorvastatin Calcium | 90 in 1 BOTTLE | TABLET | 90 | 2 | |
| 71335-2591-4 | Atorvastatin Calcium | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 71335-2591-5 | Atorvastatin Calcium | 180 in 1 BOTTLE | TABLET | 180 | 2 | |
| 71335-2591-6 | Atorvastatin Calcium | 10 in 1 BOTTLE | TABLET | 10 | 2 | |
| 71335-2591-7 | Atorvastatin Calcium | 7 in 1 BOTTLE | TABLET | 7 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Preferred Pharmaceuticals Inc. | a92f2742-1763-4a02-94b7-e8db714eb2f4 | 2026-03-11 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | NuCare Pharmaceuticals, Inc. | 4344f574-9b86-7ae5-e063-6294a90a79e8 | 2025-11-10 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Preferred Pharmaceuticals Inc. | 7fc58ce3-f069-409b-b36f-bb23ce21fb6f | 2025-09-23 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | NuCare Pharmaceuticals, Inc. | 3ef3b6e3-83dc-e06a-e063-6394a90a152c | 2025-09-16 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Rising Pharma Holdings, Inc. | 73cefb0b-1747-4fe0-b252-377f4ed94c6f | 2025-08-18 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | NuCare Pharmaceuticals, Inc. | 3bde7950-3d25-a86e-e063-6394a90ae623 | 2025-08-08 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Bryant Ranch Prepack | 9c58c4cd-fe1c-4db7-832c-874766e4da21 | 2025-06-25 | Warnings, Adverse reactions | 209912 ANDA209912 71335-2591 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | NuCare Pharmaceuticals,Inc. | 3778125d-b3d9-2853-e063-6394a90aa863 | 2025-06-13 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Bryant Ranch Prepack | b8fa04f5-0d56-49ca-bb01-f0dd3b472164 | 2025-05-14 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Bryant Ranch Prepack | 17f779f2-48ac-4719-bf37-0ee162f91144 | 2025-04-03 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Preferred Pharmaceuticals Inc. | bb825db4-3798-4d69-8559-46b3ab0c8bd9 | 2025-03-20 | Warnings, Adverse reactions | 209912 ANDA209912 |
| atorvastatin calcium | ATORVASTATIN CALCIUM, FILM COATED | NuCare Pharmaceuticals,Inc. | faba7fc1-2e08-74ef-e053-6394a90afd04 | 2025-02-04 | Warnings, Adverse reactions | 209912 ANDA209912 |
| atorvastatin calcium | ATORVASTATIN CALCIUM, FILM COATED | NuCare Pharmaceuticals,Inc. | 0a9d4e36-305a-2120-e063-6294a90a01bd | 2025-02-03 | Warnings, Adverse reactions | 209912 ANDA209912 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Bryant Ranch Prepack | 32b40825-6b0b-4025-86f5-b4e453efea92 | 2024-06-13 | Warnings, Adverse reactions | 209912 ANDA209912 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 617311 | atorvastatin calcium 40 MG Oral Tablet | PSN | 9c58c4cd-fe1c-4db7-832c-874766e4da21 | 2 |
| 617311 | atorvastatin 40 MG Oral Tablet | SCD | 9c58c4cd-fe1c-4db7-832c-874766e4da21 | 2 |
| 617311 | atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet | SY | 9c58c4cd-fe1c-4db7-832c-874766e4da21 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71335-2591-1 | 71335259101 | 30 TABLET in 1 BOTTLE (71335-2591-1) | 30 tablet | 2025-06-04 | No | No | Current |
| 71335-2591-2 | 71335259102 | 100 TABLET in 1 BOTTLE (71335-2591-2) | 100 tablet | 2025-06-04 | No | No | Current |
| 71335-2591-3 | 71335259103 | 90 TABLET in 1 BOTTLE (71335-2591-3) | 90 tablet | 2025-06-04 | No | No | Current |
| 71335-2591-4 | 71335259104 | 60 TABLET in 1 BOTTLE (71335-2591-4) | 60 tablet | 2025-06-04 | No | No | Current |
| 71335-2591-5 | 71335259105 | 180 TABLET in 1 BOTTLE (71335-2591-5) | 180 tablet | 2025-06-04 | No | No | Current |
| 71335-2591-6 | 71335259106 | 10 TABLET in 1 BOTTLE (71335-2591-6) | 10 tablet | 2025-06-04 | No | No | Current |
| 71335-2591-7 | 71335259107 | 7 TABLET in 1 BOTTLE (71335-2591-7) | 7 tablet | 2025-06-04 | No | No | Current |